A glimpse of the ‘natural history’ of established Type 2 (non-insulin dependent) diabetes mellitus from the spectrum of metabolic and hormonal responses to a mixed meal at the time of diagnosis-Reference-Cited by-同舟云学术

A glimpse of the ‘natural history’ of established Type 2 (non-insulin dependent) diabetes mellitus from the spectrum of metabolic and hormonal responses to a mixed meal at the time of diagnosis

Published:1994-12 Issue:3 Volume:26 Page:177-187
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Coates Philip A.,Ollerton Richard L.,Luzio Stephen D.,Ismail Ikrams,Owens David R.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference31 articles.

1. Pathogenesis of NIDDM: a balanced overview;DeFronzo;Diabetes Care,1992

2. The metabolic profile of NIDDM is fully established in glucose tolerant offspring of two Mexican-American parents;Gulli;Diabetes,1992

3. Decreased sensitivity of the pancreatic B-cell to glucose in prediabetic and diabetic subjects. A dose-response study;Cerasi;Diabetes,1972

4. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin dependent diabetes;O'Rahilly;N. Engl. J. Med.,1988

5. Early metabolic defects in persons at risk for non-insulin dependent diabetes mellitus;Eriksson;N. Engl. J. Med.,1989

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pathophysiology of glucose intolerance in newly diagnosed, untreated T2DM;Acta Diabetologica;2021-09-24

2. Sex-Specific Association of Serum 25-Hydroxyvitamin D₃ with Insulin Resistance in Chinese Han Patients with Newly Diagnosed Type 2 Diabetes Mellitus;Journal of Nutritional Science and Vitaminology;2018

3. Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making;Therapeutic Advances in Endocrinology and Metabolism;2014-10

4. Incretin-based therapy in combination with basal insulin: A promising tactic for the treatment of type 2 diabetes;Diabetes & Metabolism;2013-02

5. Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings;Diabetes, Obesity and Metabolism;2012-06-29